Comparing outcomes of transcatheter tricuspid valve replacement and medical therapy for symptomatic severe tricuspid regurgitation: a retrospective study-Reference-Cited by-同舟云学术

Comparing outcomes of transcatheter tricuspid valve replacement and medical therapy for symptomatic severe tricuspid regurgitation: a retrospective study

Published:2024-08-05 Issue:1 Volume:29 Page:
ISSN:2047-783X
Container-title:European Journal of Medical Research
language:en
Short-container-title:Eur J Med Res

Author:

Wang Yiwei,Liu Yang,Meng Xin,Zhai Mengen,Jin Ping,Lu Fanglin,Yang Jian

Funder

Development and Transformation of New Technology and Construction of Precision Diagnosis and Treatment System for Transcatheter Interventional Diagnosis and Treatment of Structural Heart Diseases

National Key Research and Development Programs

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s40001-024-01947-9.pdf

Reference31 articles.

1. Hahn RT. Tricuspid regurgitation. N Engl J Med. 2023;388(20):1876–91.

2. Topilsky Y, Maltais S, Medina Inojosa J, et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging. 2019;12(3):433–42.

3. Wang N, Fulcher J, Abeysuriya N, et al. Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis. Eur Heart J. 2019;40(5):476–84.

4. Messika-Zeitoun D, Verta P, Gregson J, et al. Impact of tricuspid regurgitation on survival in patients with heart failure: a large electronic health record patient-level database analysis. Eur J Heart Fail. 2020;22(10):1803–13.

5. Taramasso M, Gavazzoni M, Pozzoli A, et al. Tricuspid regurgitation: predicting the need for intervention, procedural success, and recurrence of disease. JACC Cardiovasc Imaging. 2019;12:605–21.